GlaxoSmithKline Consumer Healthcare Ltd records 16% growth for Q3, FY 2014-15
The company recorded its PAT at Rs. 96 crores, growing by 21% for the same period and PBT at Rs. 147 crores.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “Despite the category slowdown, we are delighted to show the strongest growth in the FMCG sector in the quarter. This is a clear sign of the consumer acceptance of our products based on high science. Category leader Horlicks is now joined by Boost as the top three HFD chosen by the consumers. Science, innovation, strong distribution and consumer insight based communication remain our growth levers, enabling us to drive growth while we continue to our consumers to do more, feel better and live longer.”
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
